image
CRISPR Therapeutics AG CRSP
Healthcare - Biotechnology - NASDAQ - CH
Watchlist
$ 47.25
0.854 %
$ 4.03 B
Market Cap
-18.03
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 85038.99% 76.37% 66.94%
Annual Report FY 10-K 2022-12-31 -99.95% -172.16% -180.22%
Annual Report FY 10-K 2021-12-31 168054.88% 208.25% 205.39%
Annual Report FY 10-K 2020-12-31 -99.81% -521.80% -758.31%
Annual Report FY 10-K 2019-12-31 9169.85% 140.52% 129.41%
Annual Report FY 10-K 2018-12-31 -92.38% -141.35% -145.86%
Annual Report FY 10-K 2017-12-31 693.90% -194.62% 5.11%
Annual Report FY 10-K 2016-12-31 1990.69% 10.17% -164.80%
Annual Report FY 10-K 2015-12-31 0.00% -279.82% -288.25%
Annual Report FY 10-K 2014-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% 23.37% 16.83%
Quarterly Report Q2 8-K 2024-06-30 -99.26% -62.60% -58.85%
Quarterly Report Q1 8-K 2024-03-31 -99.50% -119.71% -118.01%
Quarterly Report Q4 8-K 2023-12-31 3333233.33% 180.80% 152.90%
Quarterly Report Q3 8-K 2023-09-30 0.00% 35.75% 27.40%
Quarterly Report Q2 8-K 2023-06-30 44203.80% 58.17% 48.04%
Quarterly Report Q1 8-K 2023-03-31 56079.78% 70.39% 63.35%
Quarterly Report Q4 8-K 2022-12-31 -99.95% 21.72% 9.72%
Quarterly Report Q3 8-K 2022-09-30 -71.43% -37.27% -41.55%
Quarterly Report Q2 8-K 2022-06-30 -99.98% -24.48% -24.03%
Quarterly Report Q1 8-K 2022-03-31 -11.88% -58.37% -53.63%
Quarterly Report Q4 8-K 2021-12-31 6264.95% -31.96% -35.20%
Quarterly Report Q3 8-K 2021-09-30 122.30% -37.55% -39.45%
Quarterly Report Q2 8-K 2021-06-30 2045813.64% 1053.13% 1045.13%
Quarterly Report Q1 8-K 2021-03-31 28.66% -62.29% -55.66%
Quarterly Report Q4 8-K 2020-12-31 -99.75% -350.46% -981.16%
Quarterly Report Q3 8-K 2020-09-30 -99.93% -66.78% -66.40%
Quarterly Report Q2 8-K 2020-06-30 -86.16% -48.34% -46.75%
Quarterly Report Q1 8-K 2020-03-31 -52.13% -44.05% -51.96%
Quarterly Report Q4 8-K 2019-12-31 66870.43% 164.18% 124.28%
Quarterly Report Q3 8-K 2019-09-30 37542.63% 372.96% 381.52%
Quarterly Report Q2 8-K 2019-06-30 -70.77% -39.91% -47.46%
Quarterly Report Q1 8-K 2019-03-31 -75.85% -71.05% -79.36%
Quarterly Report Q4 8-K 2018-12-31 -99.64% -33751.77% -4653.09%
Quarterly Report Q3 8-K 2018-09-30 -76.41% -105.25% -109.72%
Quarterly Report Q2 8-K 2018-06-30 -69.63% -71.99% -75.00%
Quarterly Report Q1 8-K 2018-03-31 -49.76% -31.78% -30.14%
Quarterly Report Q4 8-K 2017-12-31 1279.05% -99.18% 103.84%
Quarterly Report Q3 8-K 2017-09-30 54.10% -68.14% -61.33%
Quarterly Report Q2 8-K 2017-06-30 350.57% -30.01% -28.67%
Quarterly Report Q1 8-K 2017-03-31 467.86% -154.38% -78.03%
Quarterly Report Q4 8-K 2016-12-31 848.99% 239.17% -108.04%
Quarterly Report Q3 8-K 2016-09-30 0.00% -131.26% -135.57%
Quarterly Report Q2 8-K 2016-06-30 0.00% -371.15% -356.77%
Quarterly Report Q1 8-K 2016-03-31 0.00% -160.80% -211.88%
Quarterly Report Q4 8-K 2015-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2015-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2015-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2015-03-31 0.00% 0.00% 0.00%